On Jun 22, 2026, IVF reported earnings of -3.38 USD per share (EPS) for Q1 26, missing the estimate of -1.26 USD, resulting in a -167.72% surprise. Revenue reached 2.02 million, compared to an expected 2.00 million, with a 0.76% difference. The market reacted with a -7.33% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.70 USD, with revenue projected to reach 2.42 million USD, implying an decrease of -79.29% EPS, and increase of 20.10% in Revenue from the last quarter.